Scientists test new drug delivery method in healthy volunteers
NCT ID NCT07236411
Summary
This early-stage study aims to measure how much of an experimental drug called cizutamig gets into the bloodstream when given as a simple injection under the skin, compared to an intravenous (IV) drip. Researchers will enroll 20 healthy adult volunteers to receive a single dose by one of these two methods. The main goal is to understand the drug's absorption, while closely monitoring safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS STUDY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nucleus Network
RECRUITINGMelbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.